Correlation Between ContraFect Corp and Aridis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both ContraFect Corp and Aridis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ContraFect Corp and Aridis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ContraFect Corp and Aridis Pharmaceuticals, you can compare the effects of market volatilities on ContraFect Corp and Aridis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ContraFect Corp with a short position of Aridis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of ContraFect Corp and Aridis Pharmaceuticals.
Diversification Opportunities for ContraFect Corp and Aridis Pharmaceuticals
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between ContraFect and Aridis is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding ContraFect Corp and Aridis Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aridis Pharmaceuticals and ContraFect Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ContraFect Corp are associated (or correlated) with Aridis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aridis Pharmaceuticals has no effect on the direction of ContraFect Corp i.e., ContraFect Corp and Aridis Pharmaceuticals go up and down completely randomly.
Pair Corralation between ContraFect Corp and Aridis Pharmaceuticals
If you would invest (100.00) in Aridis Pharmaceuticals on May 15, 2025 and sell it today you would earn a total of 100.00 from holding Aridis Pharmaceuticals or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
ContraFect Corp vs. Aridis Pharmaceuticals
Performance |
Timeline |
ContraFect Corp |
Risk-Adjusted Performance
Weakest
Weak | Strong |
Aridis Pharmaceuticals |
Risk-Adjusted Performance
Weakest
Weak | Strong |
ContraFect Corp and Aridis Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with ContraFect Corp and Aridis Pharmaceuticals
The main advantage of trading using opposite ContraFect Corp and Aridis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ContraFect Corp position performs unexpectedly, Aridis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aridis Pharmaceuticals will offset losses from the drop in Aridis Pharmaceuticals' long position.ContraFect Corp vs. Palisade Bio | ContraFect Corp vs. Allarity Therapeutics | ContraFect Corp vs. Cns Pharmaceuticals | ContraFect Corp vs. Windtree Therapeutics |
Aridis Pharmaceuticals vs. Adial Pharmaceuticals | Aridis Pharmaceuticals vs. Transcode Therapeutics | Aridis Pharmaceuticals vs. Aditxt Inc | Aridis Pharmaceuticals vs. Reviva Pharmaceuticals Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |